[ASAP] PROTAC: Harnessing Targeted Chimeras for Selective BCL ‑2 Degradation in Cancer Treatment

ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.3c00113

Source: ACS Medicinal Chemistry Letters - April 13, 2023 Category: Chemistry Authors: Robert B. Kargbo Source Type: research